Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

China flag China · Delayed Price · Currency is CNY
18.64
+0.47 (2.59%)
Jan 23, 2026, 3:00 PM CST
162.17%
Market Cap7.65B
Revenue (ttm)671.33M
Net Income (ttm)-87.10M
Shares Out420.78M
EPS (ttm)-0.25
PE Ration/a
Forward PE528.38
Dividendn/a
Ex-Dividend Daten/a
Volume14,610,155
Average Volume11,997,151
Open18.62
Previous Close18.17
Day's Range17.80 - 18.92
52-Week Range7.10 - 22.55
Beta0.52
RSI54.13
Earnings DateMar 31, 2026

About SHA:688488

Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally. The company offers anti-virus products, such as ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets. It also exports its products. The company was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. and changed its name to Jiangsu Aidea Pharmaceutical Group Co., Ltd. in July... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 704
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688488
Full Company Profile

Financial Performance

In 2024, SHA:688488's revenue was 417.80 million, an increase of 1.57% compared to the previous year's 411.36 million. Losses were -141.20 million, 85.6% more than in 2023.

Financial Statements